TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  News From NINDS  »  News Articles  » 

Skip secondary menu

NIH to Host Research Symposium on Clinical Applications of Stem Cell Therapies

For release: Tuesday, April 1, 2008

What:     "Challenges and Promise of Cell-Based Therapies" is a one-day symposium to explore promising research in regenerative medicine using stem cells. The opening plenary session will feature an overview of hematopoietic stem cell therapy. This will be followed by four plenary sessions that will highlight cell-based therapies for the treatment of neurological, cardiac, musculoskeletal, and metabolic diseases and disorders. It will close with a presentation on induced pluripotent stem cells (iPSCs) and the issues that need to be addressed to enable their potential use in cell-based therapies.  

Why:       The purpose of the symposium is to determine productive new directions for research in regenerative medicine and to help NIH prioritize research with the greatest potential for clinical benefit.

Who:      Speakers include:

  • Story C. Landis, Ph.D.,  National Institute of Neurological Disorders and Stroke, National Institutes of Health
  • James F. Battey, Jr., M.D., Ph.D., National Institute on Deafness and Other Communication Disorders, National Institutes of Health
  • Paolo Bianco, M.D., Sapienza Universita' di Roma
  • George Daley, M.D., Ph.D., Harvard Stem Cell Institute
  • Mark S. Freedman, M.D., M.Sc., University of Ottawa
  • Linda Griffith, Ph.D., Massachusetts Institute of Technology
  • Markus Grompe, M.D., Oregon Health & Science University
  • Douglas Kerr, M.D., Ph.D., Johns Hopkins University
  • Michael A. Laflamme, M.D., Ph.D., University of Washington
  • Annarosa Leri, M.D., Harvard Medical School
  • Douglas W. Losordo, M.D., Northwestern University
  • Stuart H. Orkin, M.D., Harvard Stem Cell Institute
  • Terence A. Partridge, Ph.D., Children’s National Medical Center
  • Darwin Prockop, M.D., Ph.D., Tulane University Medical School
  • Clive N. Svendsen, Ph.D., University of Wisconsin-Madison
  • Kenneth Zaret, Ph.D., Fox Chase Cancer Center

When:    Tuesday, May 6, 2008, 8 a.m. to 5:30 p.m. 

Where:  Natcher Conference Center, NIH Campus     

Press Registration: For a registration form please send your name and email to, or call 866-710-0135 and leave your name and phone number. To be admitted into the symposium, you will need to show your press ID (or credentials) at the registration desk to receive a name badge.   

More Information:  

The National Institutes of Health (NIH) — The Nation's Medical Research Agency — includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit  


Last Modified August 7, 2009